BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

Singleron Biotechnologies Partners with Human Cell Atlas to Boost Global Adoption of Single Cell Sequencing

Singleron Biotechnologies announced a partnership with the Human Cell Atlas (HCA) to help accelerate the adoption of single cell sequencing globally. Singl...

June 19, 2024 | News

Enveda Biosciences Secures $55 Million in Latest Financing Round

Enveda Biosciences a biotechnology company using AI to translate nature into new medicines, announced today a new financing round of $55 million to add to ...

June 17, 2024 | News

Thailand BOI Approves Eight Major Projects Worth 56.95 Billion Baht

The Thailand Board of Investment (BOI) today approved investment promotion applications for eight large-scale projects totaling 56.95 billion baht (USD 1.5...

June 17, 2024 | News

Novotech Launches Early Phase Unit for Biotechs in Australian and New Zealand Clinical Environment

Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and n...

June 14, 2024 | News

Asahi Kasei Launches Innovative Membrane System for WFI Production, Reducing CO2 Emissions and Costs

Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI (water for injection), a type of sterile water that is ...

June 14, 2024 | News

NSG BioLabs Partners with Eppendorf to Propel Biotech Startups in Singapore

Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the start...

June 13, 2024 | News

Zymeworks Secures $8 Million Milestone Payment and Advances Cancer Treatment with FDA and NMPA Approvals

Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from Bei...

June 11, 2024 | News

EnGeneIC and Singapore Institute of Advanced Medicine Partner to Transform Cancer Treatment in Asia

EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has announce...

June 07, 2024 | News

Tyligand Bioscience Doses First Patient in Phase 1/2 Trial for Innovative KRAS G12D Cancer Therapy

Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the fir...

May 27, 2024 | News

Laekna Receives FDA Approval for Phase III Trial of Innovative mCRPC Treatment

Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, announced that the company has received approval from the U.S. Food an...

May 24, 2024 | News

RemeGen Announces Completion of Patient Enrollment for Two Phase III Clinical Trials of Telitacicept in China

RemeGen Co. a commercial-stage biotechnology company, recently announced significant progress of Telitacicept (RC18), that two Phase III clinical tria...

May 22, 2024 | News

Nabla Bio Secures $26 Million Series A and $550 Million in Strategic Pharma Collaborations

➢ Company builds integrated AI and wet lab technologies to design developable, selective, and functionally active protein drugs against ...

May 15, 2024 | News

Brii Biosciences Secures Breakthrough Therapy Designations for Two HBV Treatments from NMPA

Brii Biosciences Limited a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need,...

May 14, 2024 | News

Cellipont Bioservices Partners with Adva Biotechnology to Launch Innovative ADVA X3® Platform

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, an Israel-based...

May 08, 2024 | News

Stay Connected